Madisen Brown

Madisen Brown

Auto-generated profile, based on publicly available information

Madisen Brown

Center for Healthcare Organization and Implementation Research (CHOIR), Boston Campus, VA Boston Healthcare System, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2024 in Implementation Research and Practice
Verified
Journal Article
Open access
CMChristopher J. Miller
Christopher J. Miller
JSJennifer L. Sullivan
Jennifer L. Sullivan
SCSamantha L. Connolly
Samantha L. Connolly
EREric J. Richardson
Eric J. Richardson
KSKelly L. Stolzmann
Kelly L. Stolzmann
BKBo Kim
Bo Kim
Background: Sustaining healthcare interventions once they have been implemented is a pivotal public health endeavor. Achieving sustainability requires context-sensitive adaptations to evidence-based practices (EBPs) or the implementation strategies used to ensure their adoption. For replicability of adaptations beyond the specific setting in question, the underlying logic needs to be clearly described, and adaptations themselves need to be plainly documented. The goal of this project was to describe the process by which implementation facilitation was adapted to improve the uptake of clinical care practices that are consistent with the collaborative chronic care model (CCM).Method: Quantitative and qualitative data from a prior implementation trial found that CCM-consistent care practices were not fully sustained within outpatient general mental health teams that had received 1 year of implementation facilitation to support uptake. We undertook a multistep consensus process to identify adaptations to implementation facilitation based on these results, with the goal of enhancing the sustainability of CCM-based care in a subsequent trial. The logic for these adaptations, and the resulting adaptations themselves, were documented using two adaptation-oriented implementation frameworks (the iterative decision-making for evaluation of adaptations [IDEA] and the framework for reporting adaptations and modifications to evidence-based implementation strategies [FRAME-IS], respectively).Results: Three adaptations emerged from this process and were documented using the FRAME-IS: (a) increasing the scope of implementation facilitation within the medical center, (b) having the internal facilitator take a greater role in the implementation process, and (c) shortening the implementation timeframe from 12 to 8 months, while increasing the intensity of facilitation support during that time.Conclusions: EBP sustainability may require careful adaptation of EBPs or the implementation strategies used to get them into routine practice. Recently developed frameworks such as the IDEA and FRAME-IS may be used to guide decision-making and document resulting adaptations themselves. An ongoing funded study is investigating the utility of the resulting adaptations for improving healthcare.

3 November 2022 in Administration and Policy in Mental Health and Mental Health Services Research
Verified
Journal Article
Closed access
PDF file
CMChristopher J. Miller
Christopher J. Miller
BKBo Kim
Bo Kim
SCSamantha L. Connolly
Samantha L. Connolly
ESElizabeth G. Spitzer
Elizabeth G. Spitzer
MBMadisen Brown
Madisen Brown
JSJennifer Sullivan
Jennifer Sullivan

1 November 2021 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
KDKimberly Dukes
Kimberly Dukes
JWJulia Walhof
Julia Walhof
MBMadisen Brown
Madisen Brown
KGKalpana Gupta
Kalpana Gupta
JSJudith Strymish
Judith Strymish
MSMarin Schweizer
Marin Schweizer
In 2019, the IDSA Clinical Practice guidelines on asymptomatic bacteriuria (ASB) recommended that clinicians no longer screen or treat patients for ASB before non-urological surgeries. However, it remains to be seen whether these guideline recommendations alone will produce changes in practice. Understanding clinical decision-making about preoperative urine screening and treatment can help design effective interventions to facilitate guideline concordance and support antibiotic stewardship. Our project objective was to qualitatively assess barriers and facilitators to reducing preoperative urine testing and treatment. We conducted semi-structured interviews with 24 participants (surgeons, advance practice providers, pharmacists, infectious disease physicians, epidemiologists) at 4 Veterans Administration hospitals. We solicited feedback on 4 proposed interventions (substitution, lab restrictions, audit and feedback, interactive workshop), and invited suggestions on other interventions. Three researchers separately coded 20% of interview notes to sort responses to each intervention into acceptable, possibly acceptable, and not acceptable. The team then compared coding, resolved differences by consensus, and refined the code dictionary to ensure intercoder agreement; then each member coded one third of remaining notes. Participants expressed concerns about de-implementing routine urine testing and treatment for specific procedures and specialties (e.g., cardiothoracic). Some actively sought to identify and treat ASB. Participants found audit and feedback and substitution of different infection-control practices most acceptable. Participants suggested changes to make interventions more acceptable or feasible (e.g., tailoring to procedure, educational tailoring). Participants also identified new potential interventions (e.g. order set changes, collaborative decision making, education on potential harms, identification of testing costs). Table 1. Acceptability of Proposed Interventions by Percentage of Participants. Percentages Do Not Add up to 100% Because Some Interviewees Did Not Answer Every Question. Interventions to optimize urine screening and treatment for patients undergoing surgeries may require tailoring for surgical specialties, and should address clinical concerns about intervention feasibility. Kalpana Gupta, MD, MPH, Abbott (Shareholder)DBC Pri-Med (Consultant)Glaxo Smith Kline (Consultant)Moderna (Shareholder)Nabriva Therapeutics (Consultant)Pfizer (Other Financial or Material Support, Grant to the institution)Qiagen (Consultant)Rebiotix (Consultant)Spero Therapeutics (Consultant)Utility Therapeutics (Consultant) Daniel Suh, MS MPH, General Electric (Shareholder)Merck (Shareholder)Moderna (Shareholder)Smile Direct Club (Shareholder) Bruce Alexander, PharmD, Bruce Alexander Consulting (Independent Contractor) Marin Schweizer, PhD, 3M (Grant/Research Support)PDI (Grant/Research Support)

19 September 2024 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
JWJulia E. Friberg Walhof
Julia E. Friberg Walhof
MSMarin L. Schweizer
Marin L. Schweizer
KGKalpana Gupta
Kalpana Gupta
MBMadisen Brown
Madisen Brown
DSDaniel Suh
Daniel Suh
KDKimberly C. Dukes
Kimberly C. Dukes
Objective: Many preoperative urine cultures are of low value and may even lead to patient harms. This study sought to understand practices around ordering preoperative urine cultures and prescribing antibiotic treatment.Design: Open-ended, semi-structured qualitative interviewsSetting: 5 Veterans Affairs hospitals.Participants: Interviews with 14 surgeons (9 surgeons, 5 surgical leaders), 7 infectious disease physicians, 8 surgical advanced practice providers (APPs), 1 surgical nurse manager, 3 infectious disease pharmacists, 1 hospitalist, and 1 lab manager.Methods: We interviewed participants using a qualitative semi-structured interview guide. Collected data was coded inductively and with the Dual Process Model (DPM) using MAXQDA software. Data in the “Testing Decision-Making” code was further reviewed using the concept of perceived risk as a sensitizing concept.Results: We identified themes relating to surgeons’ concerns about de-implementing preoperative urine cultures to detect asymptomatic bacteriuria (ASB) in patients undergoing non-urological procedures: (1) anxiety and uncertainty surrounding missing infection signs spanned surgical specialties, (2) there were perceived risks of negative consequences associated with omitting urine cultures and treatment prior to specific procedure sites and types, and additionally, (3) participants suggested potential routes for adjusting these perceived risks to facilitate de-implementation acceptance. Notably, participants suggested that leadership support and peer engagement could help improve surgeon buy-in.Conclusions: Concerns about perceived risks sometimes outweigh the evidence against routine preoperative urine cultures to detect ASB. Evidence from trusted peers may improve openness to de-implementing preoperative urine cultures.

11 August 2025 in American Journal of Infection Control
Verified
Journal Article
Closed access
KDKimberly C. Dukes
Kimberly C. Dukes
KGKalpana Gupta
Kalpana Gupta
JWJulia Friberg Walhof
Julia Friberg Walhof
MBMadisen E. Brown
Madisen E. Brown
JSJudith Strymish
Judith Strymish
MSMarin L. Schweizer
Marin L. Schweizer

19 March 2025 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
JWJulia E. Friberg Walhof
Julia E. Friberg Walhof
MSMarin L. Schweizer
Marin L. Schweizer
KGKalpana Gupta
Kalpana Gupta
MBMadisen Brown
Madisen Brown
DSDaniel Suh
Daniel Suh
KDKimberly C. Dukes
Kimberly C. Dukes
Response to Mr. Babar’s Letter to the Editor regarding “Healthcare worker attitudes on routine non-urological preoperative urine cultures: a qualitative assessment”